-
Track & Monitor
Drones in defence: Aerial cargo delivery
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the defence industry’s Aerial cargo delivery segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Company Insights
NewAir France – Digital Transformation Strategies
Air France-KLM Digital Transformation Strategies Overview Air France has been focusing on using artificial intelligence, the Internet of Things (IoT), cloud-based mobile applications, big data, and drones to digitally transform its operations. The annual ICT spending of Air France was estimated at $911.8 million for 2023. A major share of this spending is earmarked for acquiring software, hardware, and ICT services from vendors. Air France-KLM is an international airline group specializing in air passenger transport, cargo transport, and aircraft maintenance....
-
Product Insights
NewMicromobility in Insurance – Market Trends and Dynamics, 2024
Micromobility in Insurance Market Report Overview Micromobility is a term used to describe the range of lightweight vehicles designed for one or two people. It largely constitutes bicycles, e-bikes, and e-scooters and is a particularly popular form of first- and last-mile transport in urban environments. City planners and policymakers are using micromobility to encourage less private vehicle usage as part of their net-zero strategies. Shared mobility services are growing in popularity across most major cities as younger consumers make use...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pucotenlimab in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pucotenlimab in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pucotenlimab in Triple-Negative Breast Cancer (TNBC) Drug Details: Pucotenlimab (Puyouheng)...
-
Company Insights
Delta Air Lines, Inc – Digital Transformation Strategies
Delta Air Lines Inc (Delta Air Lines) has been focusing on using artificial intelligence, big data, and cloud to digitally transform its operations. The annual ICT spending of Delta Air Lines was estimated at $1.9 billion for 2023. A major share of this spending is earmarked for acquiring software, network and communications, and hardware from vendors. Delta is a global airline company, which provides scheduled air transportation for passengers and cargo. Its service portfolio includes passenger transport, cargo transport, aircraft...
-
Track & Monitor
Innovation in defence: Aerial cargo delivery
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the defence industry’s Aerial cargo delivery segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Track & Monitor
Drones in defence: Drone cargo retrieval
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the defence industry’s Drone cargo retrieval segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Camrelizumab in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Camrelizumab in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Camrelizumab in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: Camrelizumab (Airuika)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CRG-022 in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CRG-022 in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CRG-022 in Acute Lymphocytic Leukemia (ALL, Acute...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CRG-022 in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CRG-022 in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CRG-022 in B-Cell Acute Lymphocytic Leukemia...